MedPhab, Europe’s first pilot line for photonics-based medical devices, is launching an Open Call for the external companies developing medical products. The objective of the Open Call is to provide technology development services for the companies that are adopting advanced photonics technologies in the medical diagnostics solutions. As the technology development services are pioneering in nature, we provide subsidized financial support to up to 20 business cases. For small and medium enterprises (SMEs) the support is 75% of the costs and for large enterprises the support is 50%.

The MedPhab consortium consists of research organizations and industrial parties with ISO13485 certificate allowing the seamless development from early phase proof-of-concept to regulated pilot production. Depending on the phase of the development, the most suitable MedPhab party or parties are selected as developer.

Participation in the open call

The proposal submission has two stages: a pre-screening phase and a full proposal submission (more details on medphab website ).
 

Pre-screening phase: Continuous process

Next deadlines for full proposal: 28/02/2023, 30/04/2023

Expected duration of participation: 3-12 months

Maximum amount of EU-financial support for each project: 250 K€

All the enquiries are handled confidentially.